The poorer overall survival of T-ALL patients with the highest expression of CHMP5 (Figure 5D) suggested that CHMP5-regulated mechanisms dictate patient response to chemotherapy. The gene discussed is CHMP5; the disease is acute lymphoblastic leukemia.